文献速递胃肠外科围术期管理与 ERAS

药学主导的减重手术围术期药物核对:作用探讨

Pharmacy-led initiative for improving peri-operative medication reconciliation among bariatric surgical patients: what is the role?
PubMed 文献 · Surg Endosc · 2021-02-12

单中心回顾性研究评估药学主导的减重手术出院药物核对项目的可行性与效果。纳入353例患者,干预后非阿片类止痛药处方增加(39% vs 54%,P<0.001),降压药减量或停用比例提高(44.7% vs 85.4%,P<0.001),30天再入院率降低(7.6% vs 1.5%,P=0.04)。

要点

  • 药学咨询可提高减重术后降压药减量或停用比例
  • 干预后非阿片类止痛药处方使用显著增加
  • 药学主导药物核对与30天再入院率降低相关

核心结论

  • 住院药学咨询促进减重手术患者高血压管理更合理,并增加出院时非阿片类止痛药使用。

研究设计与样本

  • 单中心回顾性队列研究,比较干预前(2018年7-12月,n=158)与干预后(2019年1-12月,n=195)减重手术住院患者,共353例。

主要发现

  • 药学咨询依从性94%,77.0%的家庭用药建议被遵循。
  • 非阿片类止痛药处方使用从39%增至54%(p<0.001)。
  • 出院时平均变更或新增大药物数从3.7±1.2增至4.2±1.8(p=0.003),平均停用药物数相似(1.2±1.5 vs 1.5±1.9,p=0.09)。
  • 降压药减量或停用比例从44.7%增至85.4%(p<0.001)。
  • 30天再入院率从7.6%降至1.5%(p=0.04),门诊药物相关电话从31%增至39%(p=0.04)。

临床怎么用

  • 减重手术患者围术期可引入药学咨询以优化出院药物核对,尤其关注降压药调整与非阿片类止痛药使用。

局限性

  • 单中心回顾性设计,样本量有限,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple medication changes are common after bariatric surgery, but pharmacist assistance in this setting is not well described. This study evaluated the feasibility and effectiveness of a pharmacy-led initiative for facilitating discharge medicine reconciliation after bariatric surgery. METHODS: A standardized post-operative pharmacy consult evaluation was conducted on bariatric surgery inpatients at a single academic center starting 1/2/2019. Retrospective chart review evaluated patient characteristics, medication changes, and 30-day outcomes pre-intervention (7/2018-12/2018) and post-intervention (1/2019-12/2019). Two-sample t tests or binomial tests were used for continuous or categorical variables, respectively; a p-value of < 0.05 was deemed statistically significant. RESULTS: A total of 353 patients were identified for study inclusion (n = 158 pre-intervention, n = 195 post-intervention) with a mean age of 45 years, 87% female, and 71% sleeve gastrectomy. Overall pharmacy consultation compliance was 94% with 77.0% of home medication recommendations followed. Non-narcotic pain medication prescription use significantly increased (39% pre- vs. 54% post-intervention; p < 0.001). At discharge, the average number of changed or new medications significantly increased (3.7 ± 1.2 pre- vs. 4.2 ± 1.8 post-intervention; p = 0.003) while the average number of stopped medications was similar (1.2 ± 1.5 pre- vs. 1.5 ± 1.9 post-intervention; p = 0.09). Anti-hypertensive medications were decreased or stopped substantially more often with pharmacist input (44.7% pre- vs. 85.4% post-intervention; p < 0.001). Three medication-related readmissions happened pre-intervention with none post-intervention. Outpatient medication-related phone calls did considerably increase (31% pre- vs. 39% post-intervention; p = 0.04), while overall 30-day readmissions significantly decreased (7.6% pre- vs. 1.5% post-intervention; p = 0.04). CONCLUSIONS: Inpatient pharmacy consultation facilitated rapid alteration to more appropriate therapy for hypertension management and significantly increased use of non-narcotic pain medications upon discharge among bariatric surgery patients. Improved protocol adherence is anticipated with program maturity and patient education interventions will be deployed to address outpatient phone calls.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Falconer EA, Harris DA, Van Prooyen A, et al. Pharmacy-led initiative for improving peri-operative medication reconciliation among bariatric surgical patients: what is the role? Surg Endosc. 2021. PMID: 33580318. doi:10.1007/s00464-021-08343-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。